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2016.08.004Abstract Four new phenolic glycosides, including two ﬂavonoid glycosides (1 and 2) and two lignan
glycosides (3 and 4), were isolated from the traditional Chinese medicine formula, Baoyuan decoction.
Their structures were established by detailed analysis of the NMR and HR-ESI-MS spectroscopic data and
their absolute conﬁgurations were determined by the experimental electronic circular dichroism data as
well as chemical methods. Furthermore, the sources of the four new compounds were determined by the
UPLC-Q-trap-MS method, which proved that 1 and 2 are originated from Glycyrrhiza uralensis, and 3
and 4 are from Cinnamomum cassia.
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Table 1 The 1H NMR and 13C NMR data for compounds 1
and 2 (δ in ppm, J in Hz, in DMSO-d6).
Position 1 2
δH δC δH δC
2 5.52 dd (13.0,
3.0)
78.7 5.50 dd (13.0, 3.0) 78.9
3 2.66 dd (14.5,
3.0)
43.3 2.64 dd (14.5, 3.0) 43.3
3.12 dd (14.5,
13.0)
3.10 dd (14.5,
13.0)
4 189.9 190.0
5 7.65 d (8.7) 128.4 7.66 d (8.7) 128.4
6 6.51 dd (8.7,
2.2)
110.6 6.52 dd (8.7, 2.2) 110.6
7 164.7 164.8
8 6.34 d (2.2) 102.6 6.36 d (2.2) 102.6
9 163.0 163.2
10 113.5 113.5
10 132.5 132.5
20 7.43 d (8.7) 127.8 7.46 d (8.7) 128.2
30 7.11 d (8.7) 116.4 7.13 d (8.7) 116.5
Xiaoli Ma et al.21. Introduction
Baoyuan decoction (BYD), a well-known traditional Chinese
medicine (TCM) formula, has been used for the treatment of aplastic
anemia, chronic renal failure, coronary heart disease, etc1–3. It is
comprised of four commonly used TCMs, i.e. Ginseng Radix et
Rhizoma, Astragali Radix, Glycyrrhizae Radix et Rhizoma Praepar-
ata Cum Melle, and Cinnamomi Cortex. In our previous studies, 31
ﬂavonoids were isolated from the extract of BYD, and three of them
are new compounds4,5. As an ongoing search for bioactive con-
stituents from BYD, four new phenolic glycosides, including two
ﬂavonoid glycosides, liquiritigenin-40-O-β-D-glucopyranosyl(1-2)-
β-D-glucopyranoside (1) and liquiritigenin-4'-O-α-d-glucopyr-
anosyl(1-6)-β-D-glucop-yranoside (2), and two lignan glycosides,
(þ)-(7S,8R,80R)-isolariciresinol-4-O-β-D-apiofuranosyl(1-2)-β-d-
glucopyranoside (3) and (þ)-(7S,8R,80R)-isolariciresin-ol-30-O-β-D-
apiofuranosyl(1-2)-β-D-glucopyranoside (4),were obtained from
the aqueous extract of BYD. Herein, the isolation and structure
elucidation of these four new components and their inhibitory effects
on lipopolysaccharide (LPS)-induced nitric oxide (NO) production in
RAW 264.7 macrophages are reported, along with their source
clariﬁcation.40 157.4 157.6
50 7.11 d (8.7) 116.4 7.13 d (8.7) 116.5
60 7.43 d (8.7) 127.8 7.47 d (8.7) 128.2
Glc
10 0 4.99 d (7.0) 99.1 4.80 d (6.5) 100.9
20 0 3.50 dd (7.5,
7.0)
82.8 3.52 dd (7.0, 6.5) 72.5
30 0 3.50 m 75.9 3.61 m 73.2
40 0 3.23 m 69.4 3.28 m 70.0
50 0 3.38 m 77.0 3.39 m 75.0
60 0 3.72 d (4.5) 60.6 3.69 d (5.0) 66.4
Glc0
10 0 0 4.49 d (7.8) 104.7 4.69 d (3.0) 98.4
20 0 0 3.00 dd (7.8,
7.0)
74.8 3.42 dd (3.0, 7.0) 71.9
30 0 0 3.13 m 76.9 3.00 m 73.2
40 0 0 3.12 m 69.6 3.17 m 70.1
50 0 0 3.19 m 76.2 3.37 m 76.7
60 0 0 3.70 dd (10.0,
2.0)
60.7 3.64 dd (11.0, 2.0) 60.7
3.46 dd (10.0,
6.0)
3.51 dd (11.0,
5.5)2. Results and discussion
Compounds 1 and 2 were both obtained as a light yellow
amorphous powder. Their molecular formulae were estab-
lished as C27H32O14 from the
13C NMR and HR-ESI-MS data
(m/z 579.1711 [M–H] for 1 and m/z 579.1708 [M–H] for
2, Calcd. for 579.1714), indicating that they were a pair of
isomers with the same formula. Their IR spectra displayed
identical absorption bands at 3402 cm1 (hydroxy group),
1647 cm1 (conjugated carbonyl group), 1598, 1502, and
1460 cm1 (phenyl group). The 1H NMR data showed the
presence of three characteristic aliphatic signals of ﬂavanone
[δH 3.12 (1 H, dd, J¼14.5, 13.0 Hz, H-3a), 2.66 (1 H, dd,
J¼14.5, 3.0 Hz, H-3b), and 5.52 (1 H, dd, J¼13.0, 3.0 Hz,
H-2) for 1; δH 3.10 (1 H, dd, J¼14.5, 13.0 Hz, H-3a), 2.64
(1 H, dd, J¼14.5, 3.0 Hz, H-3b), and 5.50 (1 H, dd, J¼13.0,
3.0 Hz, H-2) for 2], a group of ABX coupled phenyl proton
signals [δH 7.65 (1 H, d, J¼8.7 Hz, H-5), 6.51 (1 H, dd,
J¼8.7, 2.2 Hz, H-6), and 6.34 (1 H, d, J¼2.2 Hz, H-8) for 1;
δH 7.66 (1 H, d, J¼8.7 Hz, H-5), 6.52 (1 H, dd, J¼8.7,
2.2 Hz, H-6), and 6.36 (1 H, d, J¼2.2 Hz, H-8) for 2], a group
of AA0BB0 coupled aromatic signals [δH 7.43 (2 H, d, J¼8.7
Hz, H-20, 60) and 7.11 (2 H, d, J¼8.7 Hz, H-30, 50) for 1; δH
7.46 (2 H, d, J¼8.7 Hz, H-20, 60) and 7.13 (2 H, d, J¼8.7 Hz,
H-30, 50) for 2], and two anomeric proton signals [δH 4.99
(1 H, d, J¼7.0 Hz, H-10 0) and 4.49 (1 H, d, J¼7.8 Hz, H-10 00)
for 1; δH 4.80 (1 H, d, J¼6.5 Hz, H-10 0) and 4.69 (1 H, d,
J¼3.0 Hz, H-10 0 0) for 2]. The 13C NMR data (Table 1) showed
27 carbon signals, including 12 phenyl carbons, two aliphatic
carbons, one carbonyl carbon, and two groups of glucosyl
carbons. The above data suggested that 1 and 2 are a pair of
ﬂavanone diglycosides with the same aglycone, and the
aglycone was determined as liquiritigenin by comparison
with the literature6. In acid hydrolysis, both of them yielded
two D-glucose after HPLC separation and optical rotation
measurement. For compound 1, these two glucosyls were
deduced to be both β-conﬁgured from the J values of the
anomeric protons (J¼7.0 Hz, H-10 0; J¼7.8 Hz, H-10 00). ForPlease cite this article as: Ma Xiaoli, et al. Four new phenolic glycosides from
org/10.1016/j.apsb.2016.08.004compound 2, the two glucosyls were deduced to be β- and α-
conﬁgured, respectively, from their different J values of the
anomeric protons [J¼6.5 Hz, H-10 0; J¼3.0 Hz, H-10 0 0 for 2].
An in-depth analysis of their 2D NMR data supported that 1
and 2 possess the different linkage position of the terminal
glucosyl moiety (Fig. 1). For compound 1, the HMBC
correlations of H-10 0/C-40 and H-10 0 0/C-200 suggested that the
linkage positions of the two glucosyls are at C-40 and C-20 0,
respectively. However, the HMBC correlations of H-10 0/C-40
and H-100 0/C-60 0 in 2 suggested that the linkage positions of
the two glucosyls are at C-40 and C-60 0, respectively. The
absolute conﬁguration of the aglycone of 1 and 2 was
determined as 2S from the negative Cotton effect at 300 nm
in the experimental ECD spectra (see Supplementary
Information Figs. S7 and S14), which is in accordance with
that of other natural ﬂavanone7–9. Thus, compounds 1 and 2Baoyuan decoction. Acta Pharmaceutica Sinica B (2016), http://dx.doi.
Figure 1 Structures 1–4.
Figure 2 Key HMBC correlations (H-C) of 3 and 4.
Figure 3 Key NOE correlations (H-H) of the aglycone of 3 and 4.
Four new phenolic glycosides from Baoyuan decoction 3were determined as liquiritigenin-40-O-β-D-glucopyranosyl
(1-2)-β-D-glucopyranoside and liquiritigenin-40-O-α-D-glu-
copyranosyl(1-6)-β-D-glucopyranoside, respectively.
Compounds 3 and 4 were both obtained as a light yellow
amorphous powder. Their molecular formulae were established as
C31H42O15 from the
13C NMR and HR-ESI-MS data (m/z
653.2444 [M–H] for 3 and m/z 653.2449 [M–H] for 4, Calcd.
for 653.2445). Their IR spectra displayed the absorption bands at
3396 cm1 (hydroxy group) and 1504 and 1463 cm1 (phenyl
group). The 1H NMR data showed the presence of a 1,3,4-
trisubstituted phenyl signals [δH 6.68 (1 H, d, J¼1.5 Hz, H-2),
6.69 (1 H, d, J¼7.0 Hz, H-5), and 6.00 (1 H, dd, J¼7.0, 1.5 Hz,Please cite this article as: Ma Xiaoli, et al. Four new phenolic glycosides from
org/10.1016/j.apsb.2016.08.004H-6) for 3; δH 6.73 (1 H, d, J¼2.0 Hz, H-2), 6.59 (1 H, d,
J¼8.0 Hz, H-5), and 6.27 (1 H, dd, J¼8.0, 2.0 Hz, H-6) for 4]
and two singlet phenyl signals [δH 6.67 (1 H, s, H-20), and 6.33
(1 H, s, H-50) for 3; δH 6.58 (1 H, s, H-20), and 6.72 (1 H, s, H-50)
for 4]. The 13C NMR data showed 31 signals, including 12 phenyl
carbons, six aliphatic carbons, two methoxy carbons, and 11 sugar
moiety carbons. Comparison of the 1H and 13C NMR spectro-
scopic data of 3 and 4 with those of isolariciresinol10,11 indicated
that they are both isolariciresinol diglycosides with the same sugar
constitution. In acid hydrolysis, both of them yielded a D-glucose
and a D-apiose after HPLC separation and optical rotation
measurement, which were deduced to be both β-conﬁgured from
the J value of the anomeric proton of glucosyl moiey [δH 4.29
(1 H, d, J¼8.0 Hz, H-10 0) for 3; δH 4.71 (1 H, d, J¼7.0 Hz, H-10 0
for 4)] and the 13C NMR data of the apiosyl moiety12. These two
compounds were demonstrated to be different in the linkage site of
the sugar chain moiety from the HMBC correlation (Fig. 2). The
apiosyl moieties of 3 and 4 were both determined to be connected
at the C-20 0 of glucosyl according to the HMBC correlation of
H-100 0 to C-200. Nevertheless, the glucosyl moiety of 3 was deduced
to be linked at C-4 of isolariciresinol from the HMBC correlation
of H-10 0 to C-4, and the glucosyl moiety of 4 was linked at C-30 of
isolariciresinol from the HMBC correlation of H-100 to C-30. The
aglycones of 3 and 4 were deduced to possess the same absolute
conﬁguration by examining their ECD spectra and NOE correla-
tions. Their experimental ECD spectra both showed the negative
Cotton effect at 291 nm and the positive Cotton effect at 276 nm,
indicating the 7S conﬁguration13 (see Supplementary Information,
Figs. S22 and S30). The NOE correlations between H-7/H-80/H-9a
and H-70a/H-8/H-90a were noted, while there were no NOE effects
observed between H-70a/H-80 and H-80/H-8, indicating that H-80/
H-8 and H-7/H-8 were trans-conﬁgurations (Fig. 3). Moreover, the
large coupling constants (J¼9.5 Hz for 3 and 10.6 Hz for 4)
between H-7 and H-8 also supported the above assignment10.
Thus, 8R and 80R were conﬁgured and the structures of 3 and 4
were determined as (þ)-(7S,8R,80R)-isolariciresinol-4-O-β-D-apio-
furanosyl(1-2)-β-D-glucopyranoside and (þ)-(7S,8R,80R)-isolar-
iciresinol-3'-O-β-D-apiofuranosyl(1-2)-β-D-glucopyranoside.
In order to clarify the sources of the new compounds, an UPLC-
Qtrap-MS method was established to analyze the isolates in BYD
and in each composition plant. Finally, the ﬂavonoid glycosides, 1
and 2, were found to be originated from Glycyrrhiza.uralensis,
while the lignan glycosides, 3 and 4, were derived from
Cinnamomum.cassia (Fig. 4).
The inhibitory effects of the isolates on NO production in LPS-
activated RAW 264.7 macrophage cells were screened, but
unfortunately no obvious inhibitory effects (IC504100 μmol/L)
were observed for compounds 1–4.3. Conclusions
Four new compounds, including two ﬂavonoid glycosides (1 and
2) and two lignan glycosides (3 and 4) were obtained from BYD.
The structures of these four compounds were established by
detailed spectroscopic analysis. Their absolute conﬁgurations were
determined by using experimental ECD as well as chemical
methods. Besides, 1 and 2 were found to be originated from
G. uralensis, and 3 and 4 were derived from C. cassia. However, it
is a regret to ﬁnd that all these four new isolates were inactive
against NO production in LPS-activated RAW 264.7
macrophage cells.Baoyuan decoction. Acta Pharmaceutica Sinica B (2016), http://dx.doi.
Figure 4 UPLC-Qtrap-MS base peak chromatograms (BPCs) of Baoyuan decoction (BYD) extract (A, G), G. uralensis (C), and C. cassia (I); the
extracted ion chromatograms (EICs) at m/z 579 from BYD extract (B) and G. uralensis (D); EICs at m/z 653 from BYD extract (H) and G.
uralensis (J); EICs of multiple reaction monitoring (MRM) transition (m/z 579/255) for compounds 1 and 2 (E, F); EICs of MRM transition (m/z
579/255) for compounds 3 and 4 (K, L).
Xiaoli Ma et al.44. Experimental
4.1. General experimental procedures
The NMR spectra were obtained on a Varian 500 spectrometer, with
deuterated solvent as reference. The optical rotations were deter-
mined using an AutopolsIV Automatic polarimeter. The
FT-IR spectra were measured using a Nicolet NEXUS-470 infrared
spectrometer. HR-ESI-MS spectra were recorded on a Xevo-G2
Q-TOF mass spectrometer with an electrospray ionization (ESI)
interface (Waters, Milford, MA, USA) in the negative mode.
Analytical HPLC was performed on an Agilent 1100 HPLC system,
equipped with a diode array detector and an Agilent ZORBAX SB-
Aq column (250 mm 4.6 mm, 5 μm). Semi-preparative HPLC wasPlease cite this article as: Ma Xiaoli, et al. Four new phenolic glycosides from
org/10.1016/j.apsb.2016.08.004carried out on an Agilent 1200 instrument, using an Agilent
ZORBAX SB-Aq column (250 mm 10 mm, 5 μm), detected at a
UV wavelength of 230 nm. Column chromatography (CC) was
performed on macroporous resin AB-8 (Cangzhou Bon Adsorber
Technology Co.), silica gel (100–200 mesh or 200–300 mesh,
Qingdao Haiyang Chemical Works, China), Sephadex LH-20
(Pharmacia Co.), and ODS (Merck). Analytical grade solvents were
purchased from Beijing Chemical Factory.4.2. Plant materials
The dried roots of Panax ginseng, the decoction pieces of
G. uralensis and Astragalus membranceus var. mongholicus, andBaoyuan decoction. Acta Pharmaceutica Sinica B (2016), http://dx.doi.
Table 2 The 1H NMR and 13C NMR data for compounds 3
and 4 (δ in ppm, J in Hz, in DMSO-d6).
Position 3 4
δH δC δH δC
1 136.9 133.7
2 6.68 d (1.5) 113.8 6.73 d (2.0) 114.7
3 147.7 146.5
4 145.0 144.5
5 6.69 d (7.0) 115.8 6.59 d (8.0) 114.6
6 6.00 dd (7.0,
1.5)
121.8 6.27 dd (8.0, 2.0) 122.4
7 3.67 d (9.5) 46.5 4.16 d (10.6) 44.1
8 1.88 m 38.5 1.86 m 33.8
9 3.44 m 60.4 3.37 m 59.9
10 130.4 131.4
20 6.67 s 112.3 6.58 s 117.2
30 144.8 144.3
40 146.8 147.4
50 6.33 s 116.4 6.72 s 111.8
60 133.1 129.8
70 2.76 m; 2.72 m 32.5 2.87 m; 2.54 m 31.6
80 1.68 m 45.8 1.86 m 42.9
90 3.31 m 64.1 3.41 m 63.3
OCH3 3.71 s 56.1 3.74 s 55.5
OCH3 3.69 s 56.0 3.68 s 55.6
Glc
10 0 4.29 d (8.0) 99.6 4.71 d (7.0) 99.4
20 0 3.43 dd (7.5,
7.0)
75.2 3.41 dd (7.0, 7.0) 75.3
30 0 3.26 m 77.9 3.37 m 77.2
40 0 3.18 m 69.8 3.18 m 69.4
50 0 2.76 m 77.2 3.07 m 76.8
60 0 3.44 dd (10.5,
2.0)
60.6 3.42 dd (11.0, 2.0) 60.6
3.16 dd (10.5,
5.5)
3.02 dd (11.0,
6.0)
Api
10 0 0 5.36 s 108.7 5.38 d (1.5) 108.8
20 0 0 3.70 brs 76.4 3.74 brs 76.1
30 0 0 79.8 79.3
40 0 0 4.04 d (9.0); 74.3 3.99 d (9.0); 73.9
3.56 d (9.0) 3.54 d (9.0)
50 0 0 3.28 brs 64.9 3.30 brs 64.5
Four new phenolic glycosides from Baoyuan decoction 5the barks of C. cassia were purchased from Anguo traditional
Chinese medicine market (Hebei Province, China) and authenti-
cated by Prof. Pengfei Tu. The voucher specimens (PG-AG-
20130312, GU-AG-20130312, AM-AG-20130312, and CC-AG-
20130312) were deposited at the herbarium of the Peking
University Modern Research Center for Traditional Chinese
Medicine.4.3. Extraction and isolation
The dried roots of A. membranceus var. mongholicus (30 kg),
P. ginseng (10 kg), G. uralensis (10 kg), and the barks of C. cassia
(5 kg) were powdered and mixed together according to the recordPlease cite this article as: Ma Xiaoli, et al. Four new phenolic glycosides from
org/10.1016/j.apsb.2016.08.004in Pharmacology of Traditional Chinese Medical Formulae14, and
were extracted with the deionized water (550 L 3), each for 2 h.
The extract was ﬁltered and concentrated in vacuo. The resulting
residue was dissolved in H2O and subjected to AB-8 macroporous
resin CC (30 L) eluted with aqueous EtOH solution (0%, 15%,
30%, 50%, and 95%) to give ﬁve fractions, respectively.
The 30% aqueous ethanol eluate (513.3 g) was subjected to
silica gel CC (5 kg) eluting with the mixture of CH2Cl2–
MeOH-H2O (95:5:0.5, 90:10:1, 85:15:1.5, 80:20:2 and 70:30:3)
to give 11 fractions, Frs. A-K. Fr. H was ﬁrst applied to Sephadex
LH-20 CC using MeOH as eluent to yield six fractions, Frs.
H1H6. Fr. H2 (3.49 g) was applied to silica gel CC (60.0 g)
eluting with CH2Cl2–MeOH-H2O (90:10:1, 85:15:1.5 and
70:30:3) to yield six fractions, Frs. H2aH2f. Fr. H2a (17 mg)
was further chromatographed on a semi-preparative HPLC using a
mixed solvent (15% aqueous ACN) as mobile phase to yield 1
(3.0 mg, tR 19.0 min) and 2 (2.5 mg, tR 21.0 min). Fr. F was
applied to Sephadex LH-20 CC using MeOH as eluent to yield
ﬁve fractions, Frs. F1F5. Fr. F5 (34 mg) was subjected to CC on
silica gel, using CH2Cl2–MeOH-H2O (from 85:15:1.5 to 60:40:4)
as eluent, and was then separated by HPLC, using the mixture of
ACN-H2O (12:88) to yield 3 (3.0 mg, tR 12.0 min) and 4 (2.5 mg,
tR 12.8 min).
4.3.1. Liquiritigenin-40-O-β-D-glucopyranosyl(1-2)-β-D-gluco-
pyranoside (1)
Light yellow amorphous powder; [α]23D 44 (c 0.45, MeOH);
UV (MeOH) λmax (log ε): 217 (0.72), 288 (0.35) nm; ECD
(MeOH) λmax (Δε): 300 (2.39) nm; IR (KBr) νmax: 3396,
2928, 1766, 1598, 1502, 1460, 1244, 1062, 845 and 631 cm1;
HR-ESI-MS m/z: 579.1711 [M–H] (Calcd. for C27H31O14,
579.1714); 1H NMR (DMSO-d6, 500 MHz) and
13C NMR
(DMSO-d6, 125 MHz) data see Table 1.
4.3.2. Liquiritigenin-40-O-α-D-glucopyranosyl(1-6)-β-D-gluco-
pyranoside (2)
Light yellow amorphous powder; [α]23D 34 (c 0.35, MeOH);
UV (MeOH) λmax (log ε): 217 (0.72), 288 (0.35) nm; ECD
(MeOH) λmax (Δε): 300 (2.39) nm; IR (KBr) νmax: 3396,
2928, 1766, 1598, 1502, 1460, 1244, 1062, 845, and 631 cm1;
HR-ESI-MS m/z: 579.1708 [M–H] (Calcd. for C27H31O14,
579.1714); 1H NMR (DMSO-d6, 500 MHz) and
13C NMR
(DMSO-d6, 125 MHz) data see Table 1.
4.3.3. (þ)-(7S,8R,80R)-Isolariciresinol-4-O-β-D-apiofuranosyl(1-
2)-β-D-glucopyranoside (3)
Colorless amorphous powder; [α]23D þ20.8 (c 0.13, MeOH); UV
(MeOH) λmax (log ε): 205 (0.41), 258 (0.07), 281 (0.07) nm; ECD
(MeOH) λmax (Δε): 205 (14.01), 258 (14.01), 281 (þ5.02)
nm; IR (KBr) νmax: 3396, 2925, 1767, 1504, 1463, 1375, 1244,
1049, 828, and 631 cm1; HR-ESI-MS m/z: 653.2444 [M–H]
(Calcd. for C31H41O15, 653.2445);
1H NMR (DMSO-d6,
500 MHz) and 13C NMR (DMSO-d6, 125 MHz) data see Table 2.
4.3.4. (þ)-(7S,8R,80R)-Isolariciresinol-30-O-β-D-apiofuranosyl(1-
2)-β-D-glucopyranoside (4)
Colorless amorphous powder; [α]23D þ18.4 (c 0.12, MeOH); UV
(MeOH) λmax (log ε): 205 (0.41), 258 (0.07), 281 (0.07) nm; ECDBaoyuan decoction. Acta Pharmaceutica Sinica B (2016), http://dx.doi.
Xiaoli Ma et al.6(MeOH) λmax (Δε): 205 (14.01), 258 (14.01), 281 (þ5.02)
nm; IR (KBr) νmax: 3396, 2925, 1767, 1504, 1463, 1375, 1244,
1049, 828 and 631 cm1; HR-ESI-MS m/z: 653.2449 [M–H]
(Calcd. for C31H41O15, 653.2445);
1H NMR (DMSO-d6,
500 MHz) and 13C NMR (DMSO-d6, 125 MHz) data see Table 2.
4.4. LC–MS analysis
Sample preparation: the decoction pieces of A. membranceus var.
mongholicus (100 g) were crushed into ﬁne powders and extracted
twice with 1 L of distilled water. The extract was concentrated and
the supernatant was freeze-dried. An aliquot (500 mg) of the
freeze-dried powder was dissolved into 10.0 mL of water by
vortex mixing for 1 min. After centrifugation at 9600 rpm in a
LXJ-II B centrifuge (Anke, Shanghai, China) for 10 min, the
supernatant (5 mL) was concentrated to dryness under reduced
pressure, and dissolved with 50% MeOH in water (v/v, 2 mL), and
then ﬁltered through a 0.22 μm membrane before LC–MS analysis.
The sample preparation method was same for G. uralensis,
P. ginseng, and C. cassia, and the BYD water extract.
Liquid chromatography and mass spectrometry conditions were
same as the previous report5.
4.5. Acid hydrolysis and determination of the absolute
conﬁgurations of sugars in compounds 1–4
Compounds 1 (1.5 mg), 2 (1.4 mg), 3 (1.2 mg), and 4 (2.0 mg)
were respectively hydrolyzed with 2 mol/L aqueous CF3COOH
(5 mL) by thermostat oil bath at 100 1C for 3 h. After the solvent
was removed in vacuo with MeOH, the residue was partitioned
between CH2Cl2 and H2O to give the aglycones of 1–4, which
were used for the ECD determination, along with the sugar
fractions. The sugar fractions of 1–4 were respectively passed
through a Sep-Pak C18 cartridge (Waters, Milford, MA, USA;
with 40% MeOH), and then analyzed by HPLC (MeCN–H2O
85:15; ﬂow rate, 1.0 mL/min; CHIRALYSER-MP optical rotation
detector). D-glucose (tR 19.7 min, positive optical rotation) was
detected from 1 and 2, while D-apiose (tR 7.70 min, positive
optical rotation) and D-glucose (tR 19.7 min, positive optical
rotation) were detected from 3 and 4.
4.6. Cell culture and NO measurement
The macrophage RAW 264.7 cells were obtained from Peking
Union Medical College Cell Bank (Beijing, People's Republic of
China). Cell maintenance, experimental procedures, and data
determination for the inhibition of NO production and the viability
assay are the same as previously described 5,15.
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